Daniel Skiest to Staphylococcus aureus
This is a "connection" page, showing publications Daniel Skiest has written about Staphylococcus aureus.
Connection Strength
1.287
-
Cenizal MJ, Hardy RD, Anderson M, Katz K, Skiest DJ. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization in HIV-infected ambulatory patients. J Acquir Immune Defic Syndr. 2008 Aug 15; 48(5):567-71.
Score: 0.269
-
Skiest DJ, Cooper TW. High recurrence rate of CA-MRSA skin and soft tissue infections. Arch Intern Med. 2007 Dec 10; 167(22):2527author reply 2527.
Score: 0.257
-
Skiest DJ, Brown K, Cooper TW, Hoffman-Roberts H, Mussa HR, Elliott AC. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. J Infect. 2007 May; 54(5):427-34.
Score: 0.238
-
Skiest D, Brown K, Hester J, Moore T, Crosby C, Mussa HR, Hoffman-Roberts H, Cooper T. Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic. HIV Med. 2006 Sep; 7(6):361-8.
Score: 0.235
-
Skiest DJ. Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin. J Clin Microbiol. 2006 Feb; 44(2):655-6.
Score: 0.226
-
Cenizal MJ, Skiest D, Luber S, Bedimo R, Davis P, Fox P, Delaney K, Hardy RD. Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2007 Jul; 51(7):2628-30.
Score: 0.062